Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study

Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study

Abstract Background Radiotherapy is an important treatment for patients with stage III/IV non-small cell lung cancer (NSCLC), and due to its high incidence of radiation pneumonitis, it is essential to identify high-risk people as early as possible. The present work investigates the value of the appl...

Full description

Bibliographic Details
Main Authors: Songhua Yang, Shixiong Huang, Xu Ye, Kun Xiong, Biao Zeng, Yingrui Shi
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Pulmonary Medicine
Subjects:
Radiation pneumonitis
Radiotherapy timeline
Nomogram
Risk classification system
Online Access:https://doi.org/10.1186/s12890-022-02211-8

Internet

https://doi.org/10.1186/s12890-022-02211-8

Similar Items